Vimseltinib

Chemical formula: C₂₃H₂₅N₇O₂  Molecular mass: 431.207 g/mol  PubChem compound: 86267612

Therapeutic indications

Vimseltinib is indicated for:

Tenosynovial giant cell tumour (TGCT)

Population group: only adults (18 years old or older)

Vimseltinib is indicated for treatment of adult patients with symptomatic tenosynovial giant cell tumour (TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Vimseltinib is contraindicated in the following cases:

Pregnancy

Pregnancy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈